دورية أكاديمية
أعرض في EDS

COVID-19 pandemic impact on the potential exacerbation of screening mammography disparities: A population-based study in Ontario, Canada.

التفاصيل البيبلوغرافية
العنوان: COVID-19 pandemic impact on the potential exacerbation of screening mammography disparities: A population-based study in Ontario, Canada.
المؤلفون: Fu R; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada., Tinmouth J; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada., Li Q; ICES, Toronto, Ontario, Canada., Dare A; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Hallet J; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Coburn N; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Lapointe-Shaw L; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Look Hong NJ; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Karam I; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Rabeneck L; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Krzyzanowska M; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Sutradhar R; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Eskander A; ICES, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
المصدر: Preventive medicine reports [Prev Med Rep] 2023 Dec 25; Vol. 37, pp. 102578. Date of Electronic Publication: 2023 Dec 25 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101643766 Publication Model: eCollection Cited Medium: Print ISSN: 2211-3355 (Print) Linking ISSN: 22113355 NLM ISO Abbreviation: Prev Med Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [New York, NY] : Elsevier Inc., [2014]-
مستخلص: Strategies to ramp up breast cancer screening after COVID-19 require data on the influence of the pandemic on groups of women with historically low screening uptake. Using data from Ontario, Canada, our objectives were to 1) quantify the overall pandemic impact on weekly bilateral screening mammography rates (per 100,000) of average-risk women aged 50-74 and 2) examine if COVID-19 has shifted any mammography inequalities according to age, immigration status, rurality, and access to material resources. Using a segmented negative binomial regression model, we estimated the mean change in rate at the start of the pandemic (the week of March 15, 2020) and changes in weekly trend of rates during the pandemic period (March 15-December 26, 2020) compared to the pre-pandemic period (January 3, 2016-March 14, 2020) for all women and for each subgroup. A 3-way interaction term (COVID-19*week*subgroup variable) was added to the model to detect any pandemic impact on screening disparities. Of the 3,481,283 mammograms, 8.6 % (n = 300,064) occurred during the pandemic period. Overall, the mean weekly rate dropped by 93.4 % (95 % CI 91.7 % - 94.8 %) at the beginning of COVID-19, followed by a weekly increase of 8.4 % (95 % CI 7.4 % - 9.4 %) until December 26, 2020. The pandemic did not shift any disparities (all interactions p > 0.05) and that women who were under 60 or over 70, immigrants, or with a limited access to material resources had persistently low screening rate in both periods. Interventions should proactively target these underserved populations with the goals of reducing advanced-stage breast cancer presentations and mortality.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2024 The Authors. Published by Elsevier Inc.)
References: J Med Screen. 2021 Jun;28(2):100-107. (PMID: 33241760)
Prev Med. 2021 Oct;151:106640. (PMID: 34217419)
Prev Med. 2021 Oct;151:106586. (PMID: 34217413)
Curr Oncol. 2022 Mar 10;29(3):1877-1889. (PMID: 35323353)
J Clin Epidemiol. 1988;41(5):495-501. (PMID: 3367181)
J Natl Compr Canc Netw. 2022 Feb 1;20(3):276-284. (PMID: 35104788)
Breast Cancer. 2022 Jul;29(4):740-746. (PMID: 35366175)
CMAJ Open. 2023 May 9;11(3):E426-E433. (PMID: 37160325)
J Telemed Telecare. 2022 Mar 16;:1357633X221086447. (PMID: 35296163)
Cancer Med. 2016 Jul;5(7):1670-86. (PMID: 27105926)
Curr Oncol. 2022 Oct 14;29(10):7732-7744. (PMID: 36290888)
JAMA Health Forum. 2021 Jul 2;2(7):e211408. (PMID: 35977205)
Cancer Cell. 2021 Aug 9;39(8):1042-1044. (PMID: 34265251)
Open Med. 2013 Feb 12;7(1):e9-20. (PMID: 23687535)
Curr Oncol. 2022 Aug 20;29(8):5919-5932. (PMID: 36005205)
JAMA Netw Open. 2021 May 3;4(5):e2110946. (PMID: 34028552)
Can Fam Physician. 2017 Jun;63(6):e300-e309. (PMID: 28615408)
Cancer. 2021 Jun 15;127(12):2111-2121. (PMID: 33635541)
Am J Surg. 2022 Oct;224(4):1039-1045. (PMID: 35641320)
CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338)
J Clin Pharm Ther. 2002 Aug;27(4):299-309. (PMID: 12174032)
J Public Health Manag Pract. 2022 Nov-Dec 01;28(6):615-623. (PMID: 36027607)
CMAJ Open. 2021 Dec 21;9(4):E1205-E1212. (PMID: 34933878)
Nurs Open. 2023 Sep;10(9):5843-5856. (PMID: 37259178)
Cancer Med. 2023 Mar;12(5):6056-6067. (PMID: 36176264)
JAMA Netw Open. 2023 Jan 3;6(1):e2250394. (PMID: 36626169)
Lancet Oncol. 2020 Aug;21(8):1023-1034. (PMID: 32702310)
J Med Screen. 2016 Jun;23(2):83-8. (PMID: 26355038)
Elife. 2023 Sep 12;12:. (PMID: 37698273)
BMC Public Health. 2015 Jul 21;15:679. (PMID: 26194189)
J Natl Compr Canc Netw. 2022 Nov;20(11):1190-1192. (PMID: 36351330)
JAMA. 2014 Apr 2;311(13):1336-47. (PMID: 24691609)
Sci Rep. 2022 Jul 5;12(1):11380. (PMID: 35790880)
JAMA Netw Open. 2021 Mar 1;4(3):e211104. (PMID: 33704472)
Am J Manag Care. 2022 Apr;28(3 Spec. No.):SP136-SP138. (PMID: 35285592)
JNCI Cancer Spectr. 2022 Sep 1;6(5):. (PMID: 35980176)
JAMA Oncol. 2021 Jun 1;7(6):878-884. (PMID: 33914015)
Prev Med. 2021 Oct;151:106559. (PMID: 34217410)
Cancer Causes Control. 2021 Feb;32(2):147-155. (PMID: 33392906)
Cancer Med. 2023 May;12(10):11849-11859. (PMID: 36999960)
Med Care. 1998 Jan;36(1):8-27. (PMID: 9431328)
Clin Imaging. 2021 Dec;80:205-210. (PMID: 34340204)
JAMA Netw Open. 2022 Apr 1;5(4):e228855. (PMID: 35467731)
فهرسة مساهمة: Keywords: Breast cancer screening; COVID-19; Cancer screening; Early detection of cancer; Healthcare disparity; Mammography; Pandemic; Socioeconomic factors
تواريخ الأحداث: Date Created: 20240115 Latest Revision: 20240116
رمز التحديث: 20240116
مُعرف محوري في PubMed: PMC10787238
DOI: 10.1016/j.pmedr.2023.102578
PMID: 38222304
قاعدة البيانات: MEDLINE
الوصف
تدمد:2211-3355
DOI:10.1016/j.pmedr.2023.102578